Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 57 results.
User Information
Export Records
  1. 1.   Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
  2. Anthony-Gonda, Kim; Bardhi, Ariola; Ray, Alex; Flerin, Nina; Li, Mengyan; Chen, Weizao; Ochsenbauer, Christina; Kappes, John C; Krueger, Winfried; Worden, Andrew; Schneider, Dina; Zhu, Zhongyu; Orentas, Rimas; Dimitrov, Dimiter S; Goldstein, Harris; Dropulic, Boro
  3. Science translational medicine. 2019, Aug 07; 11(504): pii: eaav5685..
  1. 2.   Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone Growth
  2. Lui, Julian C; Colbert, Max; Cheung, Crystal Sao Fong; Ad, Michal; Lee, Audrey; Zhu, Zhongyu; Barnes, Kevin M; Dimitrov, Dimiter S; Baron, Jeffrey
  3. Molecular therapy : the journal of the American Society of Gene Therapy. 2019, Mar 6; 27(3): 673-680.
  1. 3.   Biochemical and biological studies of mouse APOBEC3
  2. Nair, S.; Sanchez-Martinez, S.; Ji, X.; Rein, A.
  3. Journal of Virology. 2014, Apr; 88(7): 3850-60.
  1. 4.   IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
  2. Han, K. P.; Zhu, X. Y.; Liu, B.; Jeng, E.; Kong, L.; Yovandich, J. L.; Vyas, V. V.; Marcus, W. D.; Chavaillaz, P. A.; Romero, C. A.; Rhode, P. R.; Wong, H. C.
  3. Cytokine. 2011, Dec; 56(3): 804-810.
  1. 5.   Engineered Single Human CD4 Domains as Potent HIV-1 Inhibitors and Components of Vaccine Immunogens
  2. Chen, W. Z.; Feng, Y.; Gong, R.; Zhu, Z. Y.; Wang, Y. P.; Zhao, Q.; Dimitrov, D. S.
  3. Journal of Virology. 2011, Sep; 85(18): 9395-9405.
  1. 6.   Evidence of a Role for Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE) Machinery in HIV-1 Assembly and Release
  2. Joshi, A.; Garg, H.; Ablan, S. D.; Freed, E. O.
  3. Journal of Biological Chemistry. 2011, Aug; 286(34): 29861-29871.
  1. 7.   Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening
  2. Grohar, P. J.; Woldemichael, G. M.; Griffin, L. B.; Mendoza, A.; Chen, Q. R.; Yeung, C.; Currier, D. G.; Davis, S.; Khanna, C.; Khan, J.; McMahon, J. B.; Helman, L. J.
  3. Journal of the National Cancer Institute. 2011, Jun; 103(12): 962-978.
  1. 8.   Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model
  2. Xiao, X. D.; Zhu, Z. Y.; Dankmeyer, J. L.; Wormald, M. M.; Fast, R. L.; Worsham, P. L.; Cote, C. K.; Amemiya, K.; Dimitrov, D. S.
  3. Plos One. 2010, Oct; 5(10): 12.
  1. 9.   Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates
  2. Chen, W. Z.; Xiao, X. D.; Wang, Y. P.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Antiviral Research. 2010, Oct; 88(1): 107-115.
  1. 10.   ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION
  2. Beigel, J. H.
  3. Drugs of the Future. 2010, May; 35(5): 385-392.
  1. 11.   Purification and characterization of novel antifungal peptide, mouse beta defensin-1, in Escherichia coli
  2. Wang, Y. L.; Jiang, Y.; Yang, D.; Li, W. Y.; Gong, T. X.; Feng, Y.; Jiang, Z. H.; Li, M. Y.
  3. World Journal of Microbiology & Biotechnology. 2009 25(5): 917-920.
  1. 12.   Novel Human Interleukin-15 Agonists
  2. Zhu, X. Y.; Marcus, W. D.; Xu, W. X.; Lee, H. I.; Han, K. P.; Egan, J. O.; Yovandich, J. L.; Rhode, P. R.; Wong, H. C.
  3. Journal of Immunology. 2009 183(6): 3598-3607.
  1. 13.   Residues in the Stalk Domain of the Hendra Virus G Glycoprotein Modulate Conformational Changes Associated with Receptor Binding
  2. Bishop, K. A.; Hickey, A. C.; Khetawat, D.; Patch, J. R.; Bossart, K. N.; Zhu, Z. Y.; Wang, L. F.; Dimitrov, D. S.; Broder, C. C.
  3. Journal of Virology. 2008 82(22): 11398-11409.
  1. 14.   Mutations that alter the equilibrium between open and closed conformations of Escherichia coli maltose-binding protein impede its ability to enhance the solubility of passenger proteins
  2. Nallamsetty, S.; Waugh, D. S.
  3. Biochemical and Biophysical Research Communications. 2007, Dec; 364(3): 639-644.
  1. 15.   Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague
  2. Goodin, J. L.; Nellis, D. F.; Powell, B. S.; Vyas, V. V.; Enama, J. T.; Wang, L. C.; Clark, P. K.; Giardina, S. L.; Adamovicz, J. J.; Michiel, D. F.
  3. Protein Expression and Purification. 2007, May; 53(1): 63-79.
  1. 16.   Live vaccines for human metapneumovirus designed by reverse genetics
  2. Buchholz, U. J.; Nagashima, K.; Murphy, B. R.; Collins, P. L.
  3. Expert Review of Vaccines. 2006, Oct; 5(5): 695-706.
  1. 17.   Expression and purification of recombinant human alpha-defensins in Escherichia coli
  2. Pazgier, M.; Lubkowski, J.
  3. Protein Expression and Purification. 2006, Sep; 49(1): 1-8.
  1. 18.   Antibody-based inhibitors of HIV infection
  2. Choudhry, V.; Zhang, M. Y.; Dimitrova, D.; Prabakaran, P.; Dimitrov, A. S.; Fouts, T. R.; Dimitrov, D. S.
  3. Expert Opinion on Biological Therapy. 2006, MAY; 6(5): 523-531.
  1. 19.   Enhanced soluble protein expression using two new fusion tags
  2. Chatterjee, D. K.; Esposito, D.
  3. Protein Expression and Purification. 2006, MAR; 46(1): 122-129.
  1. 20.   Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma
  2. Khan, T.; Hixon, J. A.; Stauffer, J. K.; Lincoln, E.; Back, T. C.; Brenner, J.; Lockett, S.; Nagashima, K.; Powell, D.; Wigginton, J. M.
  3. Journal of the National Cancer Institute. 2006, FEB 1; 98(3): 190-202.
  1. 21.   Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners
  2. Nallamsetty, S.; Waugh, D. S.
  3. Protein Expression and Purification. 2006, JAN; 45(1): 175-182.
  1. 22.   Gateway vectors for the production of combinatorially-tagged His(6)-MBP fusion proteins in the cytoplasm and periplasm of Escherichia Coli
  2. Nallamsetty, S.; Austin, B. P.; Penrose, K. J.; Waugh, D. S.
  3. Protein Science. 2005, DEC; 14(12): 2964-2971.
  1. 23.   Sphingolipids: Modulators of HIV-1 infection and pathogenesis
  2. Rawat, S. S.; Johnson, B. T.; Puri, A.
  3. Bioscience Reports. 2005, OCT; 25(5-6): 329-343.
  1. 24.   DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
  2. Rosati, M.; von Gegerfelt, A.; Roth, P.; Alicea, C.; Valentin, A.; Robert-Guroff, M.; Venzon, D.; Montefiori, D. C.; Markham, P.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 2005, JUL; 79(13): 8480-8492.
  1. 25.   Efficient killing of CD22(+) tumor cells by a humanized diabody-RNase fusion protein
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Seeber, S.; Rybak, S. M.
  3. Biochemical and Biophysical Research Communications. 2005, JUN 3; 331(2): 595-602.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel